Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (13) , 1739-1746
- https://doi.org/10.1016/s0959-8049(02)00143-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphomaLeukemia, 2000
- Phase I Study of Fludarabine Plus Cyclophosphamide in Patients With Previously Untreated Low-Grade Lymphoma: Results and and Long-Term Follow-Up—A Report From the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2000
- Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomasAnnals of Oncology, 2000
- Induction of Apoptosis by 2-Chloro-2'deoxyadenosine (2-CdA) Alone and In Combination with other Cytotoxic Drugs: Synergistic Effects on Normal and Neoplastic Lymphocytes by Addition of Doxorubicin and MitoxantroneLeukemia & Lymphoma, 2000
- Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignanciesBritish Journal of Cancer, 1999
- Combination Regimen of 2-Chlorodeoxyadenosine (Cladribine), Mitoxantrone and Dexamethasone (CMD) in the Treatment of Refractory and Recurrent Low Grade Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1999
- Intermittent 2-Hour-Infusion of Cladribine as First-Line Therapy or in First Relapse of Progressive Advanced Low-Grade and Mantle Cell LymphomasLeukemia & Lymphoma, 1999
- Cladribine for Untreated or Early Low-Grade Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1998
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- MitoxantroneAmerican Journal of Clinical Oncology, 1988